Filing Details

Accession Number:
0001209191-18-020344
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-03-16 18:05:14
Reporting Period:
2018-03-14
Accepted Time:
2018-03-16 18:05:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1621328 Peony K Yu C/o Fibrogen, Inc.
409 Illinois St.
San Francisco CA 94158
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-03-14 9,891 $53.20 128,333 No 4 S Direct
Common Stock Acquisiton 2018-03-14 32,000 $0.00 160,333 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2018-03-14 55,000 $0.00 55,000 $53.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
55,000 2028-03-14 No 4 A Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 plan.
  2. Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2019, and the remainder vests in equal amounts quarterly thereafter for the following three years.
  3. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years.